Does Rallies track congressional trades in USPH?

Yes. Rallies tracks politician and congressional stock disclosures for USPH, including reported purchases, sales, dates, owners, and trade amounts when available.

Is USPH research on Rallies investment advice?

No. Rallies provides research, data, and educational context for USPH. It does not provide personalized investment advice.

USPH (US Physical Therapy Inc) Stock Analysis - Politician Trades

US Physical Therapy Inc (USPH) is a publicly traded Healthcare sector company. As of May 21, 2026, USPH trades at $62.16 with a market cap of $989.83M and a P/E ratio of 121.46. USPH moved +0.99% today. Year to date, USPH is -26.12%; over the trailing twelve months it is -21.61%. Its 52-week range spans $58.19 to $101.20. Analyst consensus is strong buy with an average price target of $97.50. Rallies surfaces USPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded USPH stock?

Recent politician trading activity in USPH includes disclosures from Gilbert Cisneros, Gil Cisneros, Josh Gottheimer, and Josh Gottheimer. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

USPH Key Metrics

Key financial metrics for USPH
Metric	Value
Price	$62.16
Market Cap	$989.83M
P/E Ratio	121.46
EPS	$0.51
Dividend Yield	0.46%
52-Week High	$101.20
52-Week Low	$58.19
Volume	184.99K
Avg Volume	0
Revenue (TTM)	$795.49M
Net Income	$52.69M
Gross Margin	19.03%

Congressional Trades in USPH

Gilbert Cisneros purchase USPH on May 20, 2025 (amount: $15.00K).
Gil Cisneros purchase USPH on Jan 29, 2025 (amount: $15.00K).
Josh Gottheimer purchase USPH on Oct 17, 2024 (amount: $15.00K) for Joint.
Josh Gottheimer sale USPH on Sep 16, 2024 (amount: $15.00K) for Joint.

Latest USPH News

U.S. Physical Therapy Secures $450M Five-Year Credit Facility with Extended Maturity — Apr 15, 2026
U.S. Physical Therapy Faces 6% Cash Flow Margin Decline and 29x Forward P/E — Mar 5, 2026
US Physical Therapy Posts 16.3% Revenue Growth, Guides $102–106M EBITDA — Mar 1, 2026
US Physical Therapy Posts 16.3% Revenue Gain on 11.2% Visits Increase — Feb 26, 2026
U.S. Physical Therapy Sees Q4 Revenue Growth Slow to 10.5% — Feb 24, 2026

Recent USPH Insider Trades

REEVE GRAHAM D. sold 662 (~$52.21K) on Mar 11, 2026.
REEVE GRAHAM D. sold 1 (~$78.52) on Mar 9, 2026.
REEVE GRAHAM D. sold 1.81K (~$148.63K) on Mar 6, 2026.

USPH Analyst Consensus

6 analysts cover USPH: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $97.50.

Common questions about USPH

Which politicians traded USPH stock?: Recent politician trading activity in USPH includes disclosures from Gilbert Cisneros, Gil Cisneros, Josh Gottheimer, and Josh Gottheimer. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in USPH?: Yes. Rallies tracks politician and congressional stock disclosures for USPH, including reported purchases, sales, dates, owners, and trade amounts when available.
Is USPH research on Rallies investment advice?: No. Rallies provides research, data, and educational context for USPH. It does not provide personalized investment advice.